Efficacy and safety of tacrolimus compared with ciclosporin a in renal transplantation: Three-year observational results

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2386-2392

  Krämer, Bernhard K ^a,r   Del Castillo, Domingo ^b   Margreiter, Raimund ^c   Sperschneider, Heide ^d   Olbricht, Christoph J ^e   Ortuño, Joaquín ^f   Sester, Urban ^g   Kunzendorf, Ulrich ^h   Dietl, Karl Heinz ⁱ   Bonomini, Vittorio ^j   Rigotti, Paolo ^k   Ronco, Claudio ^l   Tabernero, Jose M ^m   Rivero, Manuel ⁿ   Banas, Bernhard ^a   Mühlbacher, Ferdinand ^o   Arias, Manuel ^p   Montagnino, Giuseppe ^q  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d KfH Nierenzentrum Jena   (Germany)

^e KATHARINENHOSPITAL   (Germany)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g SAARLAND UNIVERSITY   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k UNIVERSITY OF PADOVA   (Italy)

^l Universitá di Vicenza   (Italy)

^m HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^o MEDICAL UNIVERSITY OF VIENNA   (Austria)

^p HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^q FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^r UNIVERSITY HOSPITAL REGENSBURG   (Germany)

more..

Author keywords

Acute rejection; Calcineurin inhibitors; Follow up; Graft survival; Patient survival

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; INSULIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FRACTURE; GRAFT FAILURE; GRAFT SURVIVAL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KAPLAN MEIER METHOD; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROEMULSION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SKIN DISEASE;

ADULT; BIOPSY; CYCLOSPORINE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; TACROLIMUS; TREATMENT OUTCOME;

EID: 46849087558     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn004     Document Type: Article

References (18)

1. Gonwa T, Johnson C, Ahsan N et al. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation 2003; 75: 2048-2053
2. Meier-Kriesche HU, Kaplan B. Ciclosporin microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with Sandimmune. Am J Transplant 2002; 2: 100-104
3. Mayer AD for the European Tacrolimus Multicentre Renal Study Group. Chronic rejection and graft half-life: five-year follow-up of the European tacrolimus multicenter renal study. Transplant Proc 2002; 34: 1491-1492
4. Jurewicz WA. Tacrolimus versus ciclosporin immunnosuppression: long-term outcome in renal transplantation. Nephrol Dial Transplant 2003; 18 (Suppl 1): 7-11
5. Vincenti F, Jensik SC, Filo RS et al. A long-term comparison of tacrolimus (FK506) and ciclosporin in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002; 73: 775-782
6. Radermacher J, Meiners M, Bramlage C et al. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transpl Int 1998; 11: 3-10
7. Margreiter R for the European Tacrolimus versus Ciclosporin Microemusion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 2002; 359: 741-746
8. Montagnino G, Krämer BK, Arias M for the European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in kidney transplantation: twelve-month follow-up. Transplant Proc 2002; 34: 1635-1637
9. Krämer BK, Montagnino G, Del Castillo D et al. Efficacy and safety of tacrolimus compared with ciclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant 2005, 20: 968-973
10. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422
11. Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
12. Chi GYH. Some issues with composite endpoints in clinical trials. Fundamental Clin Pharmacol 2005; 19: 609-619
13. Krämer BK, Zülke C, Kammerl MC et al. Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. Am J Transplant 2003; 3: 982-987
14. Johnson RWG, Kreis H, Oberbauer R et al. Sirolimus allows early ciclosporin withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 2001; 72: 777-786
15. Groth CG, Baeckman L, Morales JM et al. for the Sirolimus European Renal Transplant Study Group. Sirolimus (Rapamycin)-based therapy in human renal transplantation. Similar efficacy and different toxicity compared with ciclosporin. Transplantation 1999; 67: 1036-1042
16. Webster AC, Woodroffe RC, Taylor RS et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. Br Med J 2005; 331: 810-820
17. Wissing KM, Abramowicz D, Broeders N et al. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. Transplantation 2000; 70: 464-472
18. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 2003; 75: SS3-SS24